Hemenway Trust Hemenway Trust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$35.3M Buy
29,397
+2,237
+8% +$2.29M 2.46% 16
2026
Q1
$25M Buy
27,160
+3,083
+13% +$3.13M 2.01% 23
2025
Q4
$25.9M Buy
24,077
+6,370
+36% +$6.09M 1.98% 21
2025
Q3
$13.5M Buy
17,707
+5,752
+48% +$4.28M 1.03% 32
2025
Q2
$9.32M Buy
11,955
+6,270
+110% +$4.87M 0.72% 35
2025
Q1
$4.7M Buy
+5,685
New +$4.73M 0.38% 40

Other funds holding LLY

Hemenway Trust Hemenway Trust's LLY Position: Q2 2026 in Review

Hemenway Trust Hemenway Trust increased its Eli Lilly (LLY) stake by 8.2% in Q2 2026, buying an estimated $2.29M and bringing the position to 29,397 shares worth $35.3M. The position accounts for 2.46% of the portfolio, ranked #16.

Hemenway Trust Hemenway Trust first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Hemenway Trust Hemenway Trust held 29,397 shares of Eli Lilly worth $35.3M as of Q2 2026.
  • Hemenway Trust Hemenway Trust bought 2,237 Eli Lilly shares in Q2 2026, an estimated $2.29M.
  • Eli Lilly made up 2.46% of Hemenway Trust Hemenway Trust's portfolio in Q2 2026, its #16 holding.
  • Hemenway Trust Hemenway Trust first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Hemenway Trust Hemenway Trust's 13F filing for Q2 2026, filed 11 Aug 2026.